Literature DB >> 25370719

Minimally invasive implantation of an extracorporeal membrane oxygenation circuit used as a temporary left ventricular assist device: a new concept for bridging to permanent cardiac support.

Shunsuke Saito1, Bernhard Fleischer, Christoph Maeß, Hassina Baraki, Ingo Kutschka.   

Abstract

The implantation of cardiac assist devices is associated with poor outcome in patients with multiple organ failure and unknown neurologic status. Therefore, temporary left ventricular assist devices (LVAD) using, for example, extracorporeal centrifugal pumps may provide the chance to further evaluate the patient's clinical course and a potential qualification for implantable LVAD therapy. On the other hand, a main disadvantage of the temporary LVAD implantation is the need for redo surgery, increasing the risk of the final LVAD Implantation. To minimize this drawback of the temporary LVAD implantation, we implanted the temporary LVAD using a minimally invasive technique. The operation was done without cardiopulmonary bypass support, and the temporary LVAD was implanted through upper hemisternotomy and left anterior mini-thoracotomy. The patient recovered from multiple organ failure and was successfully bridged to a permanent LVAD therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25370719     DOI: 10.1007/s10047-014-0803-z

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  15 in total

1.  One thousand minimally invasive valve operations: early and late results.

Authors:  Tomislav Mihaljevic; Lawrence H Cohn; Daniel Unic; Sary F Aranki; Gregory S Couper; John G Byrne
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

2.  Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial.

Authors:  Georg M Wieselthaler; Gerry O Driscoll; Paul Jansz; Asghar Khaghani; Martin Strueber
Journal:  J Heart Lung Transplant       Date:  2010-06-19       Impact factor: 10.247

3.  Bridge to decision using the Levitronix CentriMag short-term ventricular assist device.

Authors:  Fabio De Robertis; Paula Rogers; Mohammed Amrani; Mario Petrou; John R Pepper; Toufan Bahrami; Gilles D Dreyfus; Asghar Khaghani; Emma J Birks
Journal:  J Heart Lung Transplant       Date:  2008-05       Impact factor: 10.247

4.  Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure.

Authors:  Shunsuke Saito; Taichi Sakaguchi; Shigeru Miyagawa; Hiroyuki Nishi; Yasushi Yoshikawa; Satsuki Fukushima; Takashi Daimon; Yoshiki Sawa
Journal:  J Heart Lung Transplant       Date:  2012-05-17       Impact factor: 10.247

5.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

6.  Minimally invasive aortic valve replacement.

Authors:  L H Cohn; D H Adams; G S Couper; D P Bichell
Journal:  Semin Thorac Cardiovasc Surg       Date:  1997-10

7.  Clinical performance with the Levitronix Centrimag short-term ventricular assist device.

Authors:  F De Robertis; E J Birks; P Rogers; G Dreyfus; J R Pepper; A Khaghani
Journal:  J Heart Lung Transplant       Date:  2006-01-06       Impact factor: 10.247

8.  The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision.

Authors:  Beth Unsworth; Roberto P Casula; Andreas A Kyriacou; Hemang Yadav; Andrew Chukwuemeka; Ashok Cherian; Rex de Lisle Stanbridge; Thanos Athanasiou; Jamil Mayet; Darrel P Francis
Journal:  Am Heart J       Date:  2010-02       Impact factor: 4.749

9.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

10.  Levitronix CentriMag to Berlin Heart Excor: a "bridge to bridge" solution in refractory cardiogenic shock.

Authors:  Antonio Loforte; Evgenij Potapov; Thomas Krabatsch; Michele Musci; Yuguo Weng; Miralem Pasic; Roland Hetzer
Journal:  ASAIO J       Date:  2009 Sep-Oct       Impact factor: 2.872

View more
  3 in total

Review 1.  Journal of Artificial Organs 2015: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; K Matsuda; E Tatsumi; G Matsumiya; T Tsukiya; T Abe; K Fukunaga; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2016-02-20       Impact factor: 1.731

2.  Diagnosis, medical treatment, and stepwise mechanical circulatory support for fulminat myocarditis.

Authors:  Shunsuke Saito; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Hiroki Hata; Daisuke Yoshioka; Keitaro Domae; Yasumasa Tsukamoto; Yasushi Sakata; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2017-12-13       Impact factor: 1.731

3.  Minimally invasive apical cannulation and cannula design for short-term mechanical circulatory support devices.

Authors:  Marcell Székely; Tamás Ruttkay; Ferenc Imre Suhai; Áron Bóna; Béla Merkely; László Székely
Journal:  BMC Cardiovasc Disord       Date:  2022-09-04       Impact factor: 2.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.